Combination therapy of lovastatin and rolipram provides neuroprotection and promotes neurorepair in inflammatory demyelination model of multiple sclerosis.

Glia
Ajaib Singh PaintliaAvtar Kaur Singh

Abstract

Drug combination therapies for central nervous system (CNS) demyelinating diseases including multiple sclerosis (MS) are gaining momentum over monotherapy. Over the past decade, both in vitro and in vivo studies established that statins (HMG-CoA reductase inhibitors) and rolipram (phosphodiesterase-4 inhibitor; blocks the degradation of intracellular cyclic AMP) can prevent the progression of MS in affected individuals via different mechanisms of action. In this study, we evaluated the effectiveness of lovastatin (LOV) and rolipram (RLP) in combination therapy to promote neurorepair in an inflammatory CNS demyelination model of MS, experimental autoimmune encephalomyelitis (EAE). Combination treatment with suboptimal doses of these drugs in an established case of EAE (clinical disease score > or = 2.0) significantly attenuated the infiltration of inflammatory cells and protected myelin sheath and axonal integrity in the CNS. It was accompanied with elevated level of cyclic AMP and activation of its associated protein kinase A. Interestingly, combination treatment with these drugs impeded neurodegeneration and promoted neurorepair in established EAE animals (clinical disease score > or = 3.5) as verified by quantitative real-tim...Continue Reading

References

May 1, 1988·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·W Krause, G Kühne
Apr 11, 1995·Proceedings of the National Academy of Sciences of the United States of America·C P GenainS L Hauser
Mar 11, 1998·Current Opinion in Immunology·A O'GarraK Gijbels
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B BielekovaR Martin
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker
Feb 7, 2002·Journal of Neuropathology and Experimental Neurology·Jerome R WujekBruce D Trapp
Mar 20, 2002·Current Neurology and Neuroscience Reports·S Markovic-Plese, H F McFarland
Oct 29, 2002·Trends in Immunology·Richard M RansohoffMoses Rodriguez
Nov 6, 2002·The Journal of Biological Chemistry·Sudeepta AggarwalAustin L Gurney
Dec 12, 2002·Multiple Sclerosis : Clinical and Laboratory Research·S Dhib-JalbutH Panitch
Jan 18, 2003·Cellular and Molecular Life Sciences : CMLS·M Kirstein, I Fariñas
Feb 1, 2003·Journal of the Neurological Sciences·Per Soelberg Sorensen
Feb 1, 2003·Journal of the Neurological Sciences·C BjartmarB D Trapp
Mar 11, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·John GreenwoodPeter Adamson
May 3, 2003·Pharmacology & Therapeutics·Suhayl Dhib-Jalbut
Mar 20, 2004·Journal of Neurochemistry·Joachim G SchulzMatthias Endres
Mar 30, 2004·Annals of Neurology·Michael H Barnett, John W Prineas
May 18, 2004·Lancet·Timothy VollmerInderjit Singh
Jun 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Elena NikulinaMarie T Filbin
Jun 16, 2004·Journal of Neuroscience Research·Ajaib Singh PaintliaInderjit Singh
Sep 11, 2004·The Journal of Pharmacology and Experimental Therapeutics·Leslie N Johnson-AnunaW Gibson Wood
Jan 7, 2005·Anatomical Science International·Qi Cui, Kwok-Fai So
May 4, 2005·Current Neurology and Neuroscience Reports·Mark J Tullman, Fred D Lublin
Jun 14, 2005·Journal of the Neurological Sciences·Marco Domeniconi, Marie T Filbin
Jun 17, 2005·Multiple Sclerosis : Clinical and Laboratory Research·Douglas R JefferyJonathon Burdette
Jun 17, 2005·Journal of Neuroimmunology·Fabrizio GiulianiV Wee Yong
Aug 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ajaib S PaintliaInderjit Singh
Sep 27, 2005·Journal of Neuroimmunology·Antonio J SánchezAntonio García-Merino
Mar 3, 2006·The New England Journal of Medicine·Richard A RudickUNKNOWN SENTINEL Investigators
Mar 18, 2006·The Journal of Clinical Investigation·Olaf StüveScott S Zamvil

❮ Previous
Next ❯

Citations

Nov 29, 2012·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Anandakumar ShunmugavelInderjit Singh
Aug 21, 2013·CNS Drugs·Amir-Hadi MaghziEmmanuelle Waubant
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Robert Vink, Alan J Nimmo
Aug 3, 2012·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Klintsy Julieta TorresPatrick Küry
Nov 30, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Alissa R CarverMaged M Costantine
Mar 25, 2014·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Cristina Ulivieri, Cosima T Baldari
May 11, 2013·Cellular and Molecular Life Sciences : CMLS·E M Medina-RodríguezF de Castro
Sep 8, 2010·Expert Review of Neurotherapeutics·Rina Aharoni
Jun 19, 2010·Progress in Neurobiology·Eilhard MixUwe K Zettl
Feb 4, 2010·Pharmacology & Therapeutics·Anneke Van der WaltTrevor Kilpatrick
Apr 28, 2009·Frontiers in Neuroendocrinology·Markus Kipp, Cordian Beyer
May 12, 2009·Progress in Neurobiology·Peter J van der MostUlrich L M Eisel
May 22, 2009·Journal of Neurochemistry·Susanne Arnold, Cordian Beyer
Aug 18, 2009·Biotechnology Journal·Pierre A Guertin
Jul 23, 2013·British Journal of Pharmacology·C González-GarcíaS Ballester
Oct 26, 2011·Brain Research Bulletin·Joshua A SmithNaren L Banik
May 4, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·D Allan ButterfieldCesare Mancuso
Jul 16, 2013·Journal of Plastic Surgery and Hand Surgery·Frédéric-Charles CloutierEric Beaumont
Feb 24, 2011·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Gesine SaherKlaus-Armin Nave
Jul 12, 2017·World Journal of Diabetes·Karen A NunleyCaterina Rosano
Mar 16, 2017·The Journal of Venomous Animals and Toxins Including Tropical Diseases·Natalia Perussi BiscolaAlexandre Leite Rodrigues Oliveira
Mar 31, 2018·Current Medicinal Chemistry·Robert HromadkaVladimir Kral
Jun 5, 2017·Metabolic Brain Disease·Seyed Soheil Saeedi SaraviAhmad Reza Dehpour
Mar 7, 2021·Cells·Giulietta Di BenedettoKonstantinos Lefkimmiatis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.